Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].

Enfermedades infecciosas y microbiologia clinica - 1 Apr 2006

Riera-Jaume Melcior, Peñaranda-Vera María, Ribas-Blanco Maria Angels, Murillas-Angoiti Javier, Campins Antoni, Salas-Aparicio Ana, Leyes-García María, Pareja-Bezares Antonio, Pérez José Luis, Villalonga-Pieras Concepción

Abstract excerpt

OBJECTIVES: To describe the use of genotype resistance testing (GRT) for virological failure in clinical practice, and the long-term clinical and virological evolution in patients for whom it is requested. To identify the predictive factors of virological failure in patients with antiretroviral (ARV) salvage therapy. METHODS: Observational study in HIV-infected patients for whom GRT was requested for virological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease Inhibitors

Share to Nucleosides

Share to Reverse Transcriptase Inhibitors

Share to Salvage Therapy

Share to Treatment Failure

Share to Virology

Source

Identifiers

PMID: 16725081
DOI: 10.1016/s0213-005x(06)73767-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].PMID 16725081Read ↗

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.Semantic proximity Read ↗

Genotypic resistance tests in the management of the HIV-infected patient at virological failure.Semantic proximity Read ↗

Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.Semantic proximity Read ↗

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.Semantic proximity Read ↗

Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia LevelsSemantic proximity Read ↗

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.Semantic proximity Read ↗

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.Semantic proximity Read ↗

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.Semantic proximity Read ↗

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.Semantic proximity Read ↗

Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care.Semantic proximity Read ↗

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads.Semantic proximity Read ↗

Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.